Jeff Cummings
Impact in
- Oncology top 5%
- Cancer Cells and Metastasis
- Lung Cancer Research Studies
- Cytokine Signaling Pathways and Interactions
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 7
- Cancer Treatment and Pharmacology 3
- Cancer Cells and Metastasis 2
- Colorectal Cancer Treatments and Studies 2
- Lung Cancer Research Studies 2
-
- Cancer therapeutics and mechanisms 3
- RNA Interference and Gene Delivery 2
- Co-authors
- Caroline Dive (14 shared papers)Malcolm Ranson (8 shared papers)Tim Ward (8 shared papers)Alastair Greystoke (4 shared papers)Duncan I. Jodrell (5 shared papers)Timothy H. Ward (5 shared papers)Paul Lorigan (2 shared papers)Andrew Hughes (3 shared papers)
- Journals
- British Journal of Cancer (4 papers)Clinical Cancer Research (3 papers)Molecular Cancer Therapeutics (2 papers)Journal of Clinical Oncology (1 paper)American Journal Of Pathology (1 paper)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Jeff Cummings
25 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 93
- Oncology 525
- Cancer Research 203
- Immunology 212
- Toxicology 34
- Reproductive Medicine 66
Countries citing papers authored by Jeff Cummings
This map shows the geographic impact of Jeff Cummings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff Cummings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff Cummings more than expected).
Fields of papers citing papers by Jeff Cummings
This network shows the impact of papers produced by Jeff Cummings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff Cummings. The network helps show where Jeff Cummings may publish in the future.
Co-authors
The 25 scholars most cited alongside Jeff Cummings, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 316 | |
| 2 | 2009 | 191 | |
| 3 | 2012 | 109 | |
| 4 | 2007 | 97 | |
| 5 | 2004 | 78 | |
| 6 | 2004 | 66 | |
| 7 | 2009 | 66 | |
| 8 | Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity. | 2003 | 56 |
| 9 | 1995 | 36 | |
| 10 | 2008 | 28 | |
| 11 | 2001 | 28 | |
| 12 | 2011 | 26 | |
| 13 | 2010 | 25 | |
| 14 | 2012 | 23 | |
| 15 | 2005 | 18 | |
| 16 | 2010 | 12 | |
| 17 | 1998 | 7 | |
| 18 | In vitro and in vivo evaluation of amylose coated pellets for colon specific drug delivery | 1993 | 5 |
| 19 | 2007 | 3 | |
| 20 | Pharmacological determinants of the antitumour activity of mitomycin C - implications for enzyme directed drug development | 1998 | 2 |
About Jeff Cummings
Jeff Cummings is a scholar working on Oncology, Molecular Biology, Toxicology, Immunology and Surgery, having authored 27 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (3 papers), Bioactive Compounds and Antitumor Agents (3 papers), Cancer therapeutics and mechanisms (3 papers), RNA Interference and Gene Delivery (2 papers), Cancer Cells and Metastasis (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Colorectal Cancer Treatments and Studies (2 papers) and Lung Cancer Research Studies (2 papers). The work is most often cited by research in Oncology (525 citations), Cancer Research (203 citations), Immunology (212 citations), Toxicology (34 citations) and Reproductive Medicine (66 citations). Jeff Cummings has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Caroline Dive, Malcolm Ranson, Tim Ward, Alastair Greystoke, Duncan I. Jodrell, Timothy H. Ward, Paul Lorigan, Andrew Hughes, John F. Smyth and Janet S. Macpherson. Their work appears in journals such as British Journal of Cancer, Clinical Cancer Research, Molecular Cancer Therapeutics, Journal of Clinical Oncology and American Journal Of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.